Atherosclerosis
Volume 210, Issue 1 , Pages 43-44 , May 2010

MMP-2 genetic variant and plaque features of instability

  • Nicola Fiotti

      Affiliations

    • Clinica Medica Generale e Terapia Medica, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy
    • Corresponding Author InformationCorresponding author at: University of Trieste, Dipartimento di Scienze Cliniche, Tecnologiche e Traslazionali. Clinica Medica. Strada di Fiume 447, Cattinara, 34149 Trieste, Italy. Tel.: +39 040 3996226; fax: +39 040 3994593.
  • ,
  • Wanfen Xiong

      Affiliations

    • Department of Surgery, University of Nebraska Medical Center, Omaha, USA
  • ,
  • Carlo Giansante

      Affiliations

    • Clinica Medica Generale e Terapia Medica, University of Trieste, Strada di Fiume 447, 34149 Trieste, Italy

Received 8 February 2010 ,Accepted 11 February 2010.

References 

  1. Johansson S, Smedsrod B. Identification of a plasma gelatinase in preparations of fibronectin. J Biol Chem. 1986;261:4363–4366
  2. Rouzier C, Vanatka R, Bannwarth S, et al. A novel homozygous MMP2 mutation in a family with Winchester syndrome. Clin Genet. 2006;69:271–276
  3. Kuzuya M, Nakamura K, Sasaki T, et al. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol. 2006;26:1120–1125
  4. Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94:2493–2503
  5. Volcik K, Campbell S, Chambless LE, et al. MMP2 genetic variation is associated with measures of fibrous cap thickness: the atherosclerosis risk in communities carotid MRI study. Atherosclerosis. 2010;
  6. Deschamps AM, Spinale FG. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc Res. 2006;69:666–676
  7. Yan C, Boyd DD. Regulation of matrix metalloproteinase gene expression. J Cell Physiol. 2007;211:19–26
  8. Qin H, Sun Y, Benveniste EN. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem. 1999;274:29130–29137
  9. Yu C, Zhou Y, Miao X, et al. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer. Cancer Res. 2004;64:7622–7628
  10. Price SJ, Greaves DR, Watkins H. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem. 2001;276:7549–7558
  11. Elliot S, Catanuto P, Fernandez P, et al. Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells. Exp Eye Res. 2008;86:653–660
  12. Goldman S, Lovett DH, Shalev E. Mechanisms of matrix metalloproteinase-2 (mmp-2) transcriptional repression by progesterone in jar choriocarcinoma cells. Reprod Biol Endocrinol. 2009;7:41
  13. Kuo L, Chang HC, Leu TH, et al. Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway. J Cell Physiol. 2006;207:729–734
  14. Pan MR, Hung WC. Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription. J Biol Chem. 2002;277:32775–32780
  15. Wang CH, Chang HC, Hung WC. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription. J Cell Physiol. 2006;208:246–252
  16. Turner NA, Hall KT, Ball SG, et al. Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. Atherosclerosis. 2007;193:36–43
  17. Staun-Ram E, Goldman S, Shalev E. p53 Mediates epidermal growth factor (EGF) induction of MMP-2 transcription and trophoblast invasion. Placenta. 2009;30:1029–1036
  18. Fiotti N, Altamura N, Fisicaro M, et al. MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis. Arterioscler Thromb Vasc Biol. 2006;26:1330–1336

PII: S0021-9150(10)00160-7

doi: 10.1016/j.atherosclerosis.2010.02.019

Atherosclerosis
Volume 210, Issue 1 , Pages 43-44 , May 2010